S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
Log in

CVE:BRM - Biorem Stock Price, Forecast & News

C$0.41
+0.00 (+1.23 %)
(As of 02/25/2020 04:00 PM ET)
Today's Range
C$0.41
Now: C$0.41
C$0.41
50-Day Range
C$0.40
MA: C$0.43
C$0.48
52-Week Range
C$0.32
Now: C$0.41
C$0.48
Volume3,100 shs
Average Volume24,462 shs
Market CapitalizationC$15.85 million
P/E Ratio3.08
Dividend YieldN/A
BetaN/A
BIOREM Inc., an environmental biotechnology company, designs, manufactures, and sells air emissions control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs) in Canada, the United States, China, and internationally. It offers biofilters for the removal of odors, H2S, VOCs and HAPs; and biotrickling filters for applications of high concentrations of H2S or other water soluble compounds. The company also provides multi-stage systems to treat odors associated with various municipal wastewater treatment processes; biogas conditioning systems; ultrafiltration membranes to treat water sources; biological odor control systems; and filter media products to treat air emissions. In addition, it offers biological processes and testing services; media sampling and analysis; system review and inspections; and media replacements and spare parts. The company is headquartered in Guelph, Canada.

Industry, Sector and Symbol

Industry Pollution & Treatment Controls
Sub-IndustryN/A
SectorIndustrials
CUSIPN/A
CIKN/A
Phone+1-519-7679100

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$27.15 million
Cash FlowC$0.14 per share
Book ValueC$0.35 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$15.85 million
Next Earnings Date3/17/2020 (Estimated)
OptionableNot Optionable

Receive BRM News and Ratings via Email

Sign-up to receive the latest news and ratings for BRM and its competitors with MarketBeat's FREE daily newsletter.


Biorem (CVE:BRM) Frequently Asked Questions

What is Biorem's stock symbol?

Biorem trades on the Canadian Venture Exchange (CVE) under the ticker symbol "BRM."

When is Biorem's next earnings date?

Biorem is scheduled to release their next quarterly earnings announcement on Tuesday, March 17th 2020. View Earnings Estimates for Biorem.

Has Biorem been receiving favorable news coverage?

Media stories about BRM stock have been trending very negative on Tuesday, InfoTrie reports. The research firm ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Biorem earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Biorem.

Who are some of Biorem's key competitors?

What other stocks do shareholders of Biorem own?

Who are Biorem's key executives?

Biorem's management team includes the folowing people:
  • Mr. Derek S. Webb, CEO, Pres & Director
  • Mr. Douglas Newman, CFO & Sec.

How do I buy shares of Biorem?

Shares of BRM and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Biorem's stock price today?

One share of BRM stock can currently be purchased for approximately C$0.41.

How big of a company is Biorem?

Biorem has a market capitalization of C$15.85 million and generates C$27.15 million in revenue each year. View Additional Information About Biorem.

What is Biorem's official website?

The official website for Biorem is http://www.biorem.biz/.

How can I contact Biorem?

Biorem's mailing address is 7496 Wellington Road 34, R.R. #3, GUELPH, ON N1H 6H9, Canada. The company can be reached via phone at +1-519-7679100.


MarketBeat Community Rating for Biorem (CVE BRM)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  56 (Vote Outperform)
Underperform Votes:  68 (Vote Underperform)
Total Votes:  124
MarketBeat's community ratings are surveys of what our community members think about Biorem and other stocks. Vote "Outperform" if you believe BRM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel